In 2008, her husband John was diagnosed with chronic obstructive pulmonary disease (COPD) - a lung disease - and he said he ...
Background: Unplanned early rehospitalization (UER) is common among lung transplant recipients, but its incidence varies among lung transplant centers. This study aimed to analyze the incidence, ...
Explore the future of organ transplants and how biotech innovations like 3D bioprinting and stem cells can solve the organ ...
Feb. 6, 2025 — Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even ...
Doctors at Northwestern Medicine say medical innovations helped them achieve two medical milestones last year: the largest number of lung transplants in a single year and the shortest median wait time ...
Lung cancer was the fifth largest leading cause of cancer deaths worldwide for those who have never smoked Vanessa Etienne is an Emerging Content Writer-Reporter for PEOPLE. Getty The proportion ...
Mansfield resident Tadd Crosslin is one of the first patients in the U.S. to receive a successful lung transplant with the help of new lung preservation technology. The "lungs in a fridge" tech ...
Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer SEATTLE — Jan. 28, 2025 — A new study shows that oral fecal microbiota ...
After being diagnosed with terminal colorectal cancer which spread to his lungs, he's one of a dozen people who received a successful double-lung transplant through groundbreaking technology last ...
Lung biopsy is a relatively frequently performed procedure with considerable benefit for patient management but it may, on rare occasions, result in the death of the patient. It is a multidisciplinary ...
Since the 1990s, a race-based method for assessing kidney function placed many Black patients lower on the transplant waitlist. However, thousands of these patients were moved up the list in ...
The Food and Drug Administration has given two biotechnology companies approval for clinical trials that will transplant organs from genetically modified pigs into patients with kidney failure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results